Using immunogold labeling of fixed, cryosubstituted tissue sections, we compared the distribution of lysozyme, an oxidant-sensitive lamellar body protein, with that of surfactant protein A (SPA) in rat Type I1 cells, extracellular surfactant forms, and alveolar macrophages. Morphometric analysis of gold particle distribution revealed that lysozyme and SPA were present throughout the secretory and endosomal pathways of Type II cells, with prominent localization of lysozyme in the peripheral compartment of lamellar bodies. All extracellular surfactant forms were labeled for both proteins with preferential labeling of tubular myelin and unilamellar vesicles. Labeling of tubular myelin for SPA was striking when compared with that of lamellar bodies and other extracellular surfactant forms. Lamellar body-like forms and multilamellar structures were uniformly labeled for lyso-zyme, suggesting that this protein is rapidly redistributed within these forms after secretion of lysoz yme-laden lamellar bodies. By contrast, increased labeling for SPA was observed over peripheral membranes of lamellar body-like forms and multilamellar structures, apparently reflecting progressive SPA enrichment of these membranes during tubular myelin formation. The results indicate that lysozyme is an integral component of the lamellar body peripheral compartment and secreted surfactant membranes, and support the concept that lysozyme may participate in the structural organization of lung surfactant. (J Hisrochem Cytochem   40:1491-1500, 1992) 
Introduction
Alveolar Type I1 pneumocytes are specialized cells responsible for the synthesis, storage, secretion, and recycling of surfactant phospholipids, surfactant-associated proteins, and other functional components of lung surfactant (5, 15, 17) . Surfactant phospholipids, composed primarily of dipalmitoylphosphatidylcholine (DPPC), are stored in lamellar bodies, which are functionally multicompartmented organelles involved in both the secretory pathway and the endosomal-lysosomal system of these cells. In addition to phospholipids, lamellar bodies contain surfactant-associated proteins (SAP), including 6, 11, 26, 29, [37] [38] [39] and lysosomal enzymes (1, 12, 18, 20, 21) . We have also previously reported that lysozyme is a prominent lamellar body protein which is rapidly depleted after acute ozone-induced oxidant injury (30, 32) . On secretion into the alveolar hypophase, surfactant membranes are organized into various forms including tubular myelin, believed to be the primary source of phospholipid molecules that produce the monomolecular surface film at the alveolar air-liquid interface. There is also in vitro evidence that the surfactant-associated proteins SP-A and SP-B play a role in the organization of tubular myelin (10, 35, 41) .
There is little information about the structural interrelationships of surfactant phospholipids and their associated proteins within lamellar bodies and secreted surfactant membranes. This is in part due to the difficulty of preserving surfactant phospholipid membranes and tissue antigenicity for ultrastructural immunocytochemical studies of lamellar bodies and extracellular surfactant membranes. In attempts to preserve surfactant membrane morphology, researchers have employed aldehydes, osmium tetroxide, tannic acid, and/or uranyl acetate, in combination with dehydration and epoxy embedding, to produce tissue with excellent morphology but poor post-embedding antigenicity (6). Other workers used cryosubstitution (7) or cryoultramicrotomy (37-39) techniques to preserve tissue antigenicity but did not adequately preserve intracellular and extracellular surfactant membrane morphology.
A recently published technique involving cryosubstitution of 1492 HALLER, SHELLEY, MONTGOMERY, BMIS aldehyde-fixed, uranyl acetate-post-fixed lung tissue was reported to provide an adequate compromise in the morphology and antigenicity of the alveolar surfactant system (37) . With this technique, the present study compares the distribution of lysozyme and SP-A in Type I1 cells, extracellular surfactant, and alveolar macrophages.
The results indicate that lysozyme, like SP-A, is a surfactantassociated protein with preferential localization within the peripheral compartment of lamellar bodies and in tubular myelin. A portion of this study has appeared in abstract form (16).
Materials and Methods
Antibodies. Anti-human lysozyme, which crossreacts with rat lysozyme, was obtained commercially (Accurate Chemical and Scientific; Westbury, NY). Antibodies to SP-A were produced from the 72 KD dimer of SP-A, isolated from rat surfactant by preparative gel electrophoresis, and injected into rabbits (31). On immunoblotting of non-disulfide-reduced SAP, the anti-SP-A serum labeled the 72 KD dimer of SP-A and showed weaker reactions for higher molecular aggregates of this protein, as well as for the 28-36 KD monomers of SP-A. Reduction of the SAP with dithiothreitol, followed by immunoblotting with the anti-72 KD serum, yielded reaction product primarily with the 28-36 KD monomers. Non-immune rabbit serum was used as a control primary serum. The secondary antibody was goat antirabbit IgG conjugated to 10-nm gold particles, purchased from Janssen Biochimica (Accurate Chemical and Scientific).
Tissue Preparation. Lung tissue was obtained from three barrier-reared adult Fischer 344 male rats. These animals came from separate litters, and were shipped from Charles River Breeders (Kingston, NY) in filtered crates, housed in cages with filter tops, and acclimated for at least 1 week before use. The rats were housed according to National Research Counsel guidelines, with free access to food and water, and were sacrificed by intraperitoneal injection of pentobarbital. The lungs of these rats were inflation-fixed via intratracheal intubation with 2% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, at 4'C and 20 cm pressure. After an initial 15-min fixation, the lungs were maintained in an inflated state during removal from the chest cavity and were immersed in additional fixative at 4%. After 1 hr of fixation the left lung was removed, cut into 2-mm thick slices, and placed in cold 0.1 M phosphate buffer, pH 7.2, for 10 min to remove the glutaraldehyde component of the fixative. Sliced lung tissue was then diced into 0.5-mm cubes and placed in cold buffered 2% paraformaldehyde for an additional 4-hr fixation. Tissue blocks were infiltrated overnight with 2.3 M sucrose at 4°C on a tissue rotator, frozen in liquid nitrogen the following day, and introduced to the pre-cooled chamber of a Reichert CS Auto Cryosubstitution Apparatus at -9O'C (Leica; Deerfield, IL). Tissue from the three rats was fixed, cryosubstituted, and embedded separately.
Cryosubstitution was performed on the tissue following the procedure of Voorhout et al. (37, 38) . with modifications. Briefly, frozen tissue was dehydrated and stained with 0.5% uranyl acetate in 100% methanol at -9O'C for 48-72 hr, with constant stirring. The cryochamber was flushed at -9o'C with 100% methanol to remove excess uranyl acetate, the chamber temperature raised to -45'C at a rate of 2'C every 5 min, and the methanol exchanged with a 50:50 mixture of methano1:Lowicryl HM20, followed by 2 hr of stirring. Pure Lowicryl HM20 was then introduced to the chamber at -45% and stirring resumed for 2 additional hr. A fresh change of Lowicryl was made, and the tissue was infiltrated overnight at -45'C with continuous stirring. The following 2 mornings, fresh changes of Lowicryl were made and stirring was resumed. Finally, the tissue was embedded in freshly mixed Lowicryl HM20, the plastic polymerized by uluaviolet light for 2 days at -45'C, brought slowly to room temperature, and hardened for 2 additional days with w light. A minimum of two randomly selected tissue blocks per animal were thin-sectioned at room temperature, and four to six gold or purple sections per grid were placed on carbonlFormvar copper grids for immunolabeling.
Immunocytochemistry. Sections on grids from cryosubstituted lung tissue were immunolabeled as described previously (38), with minor modifications. All sections to be labeled were first conditioned for 20 min on 5% newborn calf serum in 20 mM %is buffer with 150 mM NaCl and 2.5 mM KCI (TBS), pH 8.2, at room temperature. The sections were rinsed two times each for a total of 30 sec at room temperature on separate drops of TBS, pH 8.2, containing 0.1% bovine serum albumin, 0.2% coldwater fish gelatin (Sigma; St Louis, MO) and 0.05% Tween 20 (TBS-AGT), to prevent nonspecific labeling. The sections were incubated with either a primary rabbit antibody or non-immune rabbit serum (control) at 1:50 or 1:lOO dilutions in TBS-AGT for 1-2 hr at room temperature in a moisture chamber.
After primary antibody labeling, all sections were rinsed six times for 5 min each on drops of TBS-AGT, and gold labeling of the sections was accomplished with goat anti-rabbit IgG-gold antibody at a 1:sO dilution in TBS-AGT, pH 8.2, for 1 hr at room temperature. All sections were rinsed successively six times for 5 min each on drops of TBS-AGT. then on TBS, and finally on distilled water. The sections were dried with #>O Whatman filter paper and, without further staining, viewed and photographed in a Philips 301 TEM at 60 kV with a 20-km objective aperture. Nine separate sets of gold-labeled grids were photographed for this study. Each set consisted of a minimum of six grids, with at least two grids for each of the three primary antisera. Select grids were post-stained with uranyl acetate and lead citrate or lead citrate alone to enhance identification of cell organelles.
Morphometry. Serial sections from one block were used for the morphometric analysis of label density for lysozyme or SP-A in Type I1 cells and extracellular surfactant forms found in an alveolar pouch. Pouches are observed in the corners of some alveoli, freely communicating with the alveolar space through a small opening formed by attenuated Type I epithelium, and contain one or more Type I1 cells (2.3). Evaluation of lamellar bodies and extracellular surfactant forms in the same sections permitted correlation of label density and distribution patterns for lysozyme or SP-A. For these studies, a total of 24-30 cells and over 200 pm2 of surfactant forms per immunolabeling group were photographed.
For the morphometric analysis of lamellar bodies, the total area of these organelles was divided into central and peripheral compartments. The peripheral compartment of lamellar bodies was defined as the amorphous, phospholipid membrane-free region and the first three phospholipid membranes of cross-sectioned lamellar bodies that were adjacent to a clearly defined limiting membrane. Gngential sections through this peripheral compartment did not reveal a limiting membrane around the lamellar body.
The extracellular surfactant membranes were classified into subtypes as described previously (3). These subtypes indude the following: (a) lamellar body-like forms, defined as circular, densely coiled surfactant membranes similar in size and appearance to lamellar bodies but lacking a limiting membrane; (b) multilamellar structuresmultiple. loosely coiled parallel surfactant membranes arranged in various configurations; (c) unilamellar vesicles, surfactant membranes arranged in the form of vesicles, sometimes in the form of vesicles within a vesicle; and (d) tubular myelinsurfactant membranes arranged in the characteristic lattice form of adjoining tubules. The outer three membrane profiles of lamellar body-like forms cut in crosssection were considered to be the outer membranes for the morphometric studies.
All micrographs used in the morphometric studies were printed at x 47,000. A multipurpose test grid overlay was used to obtain point counts to estimate organelle or surfactant form areas by applying the formula PslPt = AslAt, where Ps represents the number of points from the grid falling on a particular StlUCtUIe and Pt represents the total number of points falling on a cell or reference area (14). Particle densities were expressed as mean gold particles per square micrometer of organelle or surfactant form ob- 
Results
Processing of rat lung tissue by the freeze-substitution technique enabled excellent preservation of lamellar bodies and extracellular surfactant forms for immunocytochemistry (Figure 1 ) . In alveolar Type I1 cells, specific labeling for lysozyme and SP-A was observed over the organelles of the secretory-endocytic pathway, including endoplasmic reticulum, tsans-Golgi vesicles, multivesicular bodies, and lamellar bodies. The labeling for lysozyme and SP-A over these organelles was consistently higher than labeling over the nucleus and mitochondria of the Type I1 cells (p<O.Ol), as shown in Table 1 . Both proteins were characteristically found within the peripheral compartment of lamellar bodies (Figures 2a-2c ; Table l) , whereas the central areas of these organelles showed minimal nonspecific labeling that was not significantly different than over the nucleus of the Type I1 cells. In sections labeled for lysozyme, the particle density over the peripheral compartment of lamellar bodies was higher than that observed over any other Type I1 cell organelles. Minimal nonspecific labeling was observed over Type I1 cells of control sections incubated with non-immune rabbit serum in place of the primary antibody ( Figure 2d ; Table 1 ).
In all forms of extracellular surfactant membranes, label den-sity for lysozyme was significantly higher than labeling found over control sections (Table 2) . Prominent labeling was observed over tubular myelin and unilamellar vesicles ( Figure 3a ). and in these locations the particle density was similar to that observed in the peripheral compartment of lamellar bodies. In cross-sectional profiles of tubular myelin labeled for lysozyme, 96% of the 169 gold particles counted were located within 20 nm from a membrane profile, but only 57% of these particles were within 20 nm from a corner of the lattice. The multilamellar structures and lamellar body-like forms showed a similar labeling density, which was significantly lower than the labeling density over tubular myelin and unilamellar vesicles. No significant difference was observed in the particle density between central and outer membranes of lamellar body-like forms labeled for lysozyme. All extracellular surfactant forms were also specifically labeled for SP-A, with the exception of the central area of lamellar bodylike forms, which had a low label density similar to that of the central membranes of lamellar bodies. Tubular myelin showed a striking labeling for SP-A when compared with all other surfactant forms (Figures 3b and 3c ; Table 2 ). For SP-A a total of 415 particles associated with cross-sectional profiles of tubular myelin were counted. Of these particles, 98% were located within 20 nm from a membrane profile and 64% within 20 nm from a lattice comer. Unilamellar vesicles showed a higher label density for SP-A than multilamellar structures or lamellar body-like forms. In addition, gold labeling for SP-A was significantly higher over multilamellar structures than over lamellar body-like forms, primarily owing to the absence of labeling in the central regions of the latter. It is of interest that some multilamellar structures resembling unfolding lamellar bodylike forms were heavily labeled for SP-A on their outer membranes (Figure 4, arrows) . These heavily labeled membranes were often in close proximity to tubular myelin. In alveolar macrophages, labeling for lysozyme was observed over both primary and secondary lysosomes as well as the Golgi apparatus and multivesicular bodies of these cells. Lysozyme is an endogenous protein in macrophages and is stored in primary lysosomes in these cells. Surfactant membranes in phagosomes were labeled for both lysozyme and SP-A. However, labeling for SP-A was not observed in association with any other organelles of these cells ( Figure 5 ).
Discussion
As shown by the results presented, the application of cryosubstitution techniques to aldehyde-fixed, non-osmicated tissue enabled high-resolution immunocytochemical labeling of stored and secreted surfactant membranes. The omission of osmium tetroxide in the cryosubstitution medium resulted in reduced contrast of nuclear heterochromatin and mitochondrial cristae. However, the use of uranyl acetate in the substitution fluid as a membrane fixative (37) instead of osmium tetroxide (19,24,40) promoted stabilization of phospholipid membranes during low-temperature dehydration. This approach eliminated the need to etch sections with sodium metaperiodate or hydrogen peroxide, which is a common step in immunolabeling sections of osmicated tissue and results in the loss of the phospholipid membranes of Type I1 cell lamellar bodies (22). The use of non-polar, hydrophobic Lowicryl HMZO plastic as an embedding medium provided for easy sectioning of the cryosubstituted lung tissue and aided in the preservation of surfactant phospholipids. In addition, this processing technique allowed a 5-6 hr immunolabeling procedure to be employed, which is significantly shorter than the conventional 2-?,-day incubation periods for immunolabeling of epoxy-embedded tissues.
Subcellular Localization of SPA and Lysozyme in Type II Cells
Previous immunocytochemical studies have indicated that SP-A, a major surfactant-associated protein, is localized within the synthetic and secretory pathway of alveolar Type I1 cells and Clara cells (4, 29, 39) . However, there is considerable controversy concerning the localization of SP-A within lamellar bodies. Coalson et al. (6) reported gold labeling for SP-A over lamellar bodies but not over any other organelle of Type I1 cells in rat lung embedded in Epon-Araldite. In their study, phospholipid membranes of the lamellar bodies were not retained during tissue osmication and ethanol dehydration. With cryosections of rat lung tissue, Walker et al. (39) reported a low level of labeling for SP-A over the phospholipid membranes, but not over the peripheral area of lamellar bodies. In Lowicryl HM20 freeze-substituted human lung, Voorhout et al. (37) reported that labeling for SP-A was not found over lamellar bodies, although heavy labeling for SP-B was localized predominately over the well-preserved phospholipid membranes of these organelles. However, these researchers also found labeling for both SP-B and SP-A over membranes of small lamellar bodies and remnants of large lamellar bodies in gold-labeled cryosections. The apparent distribution of label for SP-A over the membranes of lamellar bodies in frozen thin sections may be the result of an antigen solubilization artifact, a phenomenon that has been observed even after glutaraldehyde fixation during immunolabeling of cryosections from lipid-rich rat brain tissue (36).
In isolated rat lamellar bodies, SP-A has been reported to constitute only 1% of the total protein present, in contrast to SP-B, which has been estimated to constitute 28% (26). This may account for the apparent lack of lamellar body labeling for SP-A in Lowicryl-embedded Type I1 cells reported by Voorhout et al. (37) and the low labeling reported herein. However, the low level of SP-A detected in isolated lamellar bodies may be in part due to its peripheral localization which could result in loss of SP-A during the lamellar body isolation procedure. There is evidence that the SP-A content of isolated lamellar bodies is insufficient for their in vitro transformation to tubular myelin and rapid formation of sur- N, nucleus; M, mitochondrion; G, Golgi complex; ER, endoplasmic reticulum. Original magnifications: a,c X  50,000; b,d x 40,000. Ban = 0.25 pm. 
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Gold particle density significantly lower than tubular myelin and unilamellar
Significantly different from all other surfactant forms.
vesicles.
face film (10). The results presented herein provide morphometric evidence that SP-A is localized, albeit at low concentrations, in the peripheral compartment of lamellar bodies, thus confirming earlier observations from this laboratory ( 4 ) . Lysozyme was first identified in alveolar Type I1 pneumocytes and macrophages in immunohistochemical studies by Spicer et al. (34) of paraffin sections of rat lung. In Type I1 cells, lysozyme was described as occurring in "a morula-like cluster of bodies which consisted of unstained cores and reactive rims." More recently, it was reported that pulmonary lysozyme is a secretory protein of Type I1 cells (33) and is expressed at high levels in these cells ( 2 5 ) . The results of the present study clearly demonstrate that lysozyme is found in both the secretory pathway (endoplasmic reticulum, Golgi apparatus, multivesicular bodies, and lamellar bodies) and the endocytic pathway (multivesicular bodies and lamellar bodies) of the Type I1 cell, with a striking preferential localization within the peripheral compartment of lamellar bodies. It should be emphasized that the precise distribution of lysozyme and SP-A in the endosomal-lysosomal compartment of these cells has not been determined.
Recent immunochemical studies have reported that SP-A and lysozyme are found in both lamellar bodies and lysosomes isolated from Type I1 cells (11,28) . The localization of lysozyme and SP-A in multivesicular bodies and in the periphery of lamellar bodies may be due in part to re-uptake of these proteins, along with extracellular surfactant material, as suggested by Kalina and Socher in their studies of gold-labeled SP-A uptake by cultured rat Type I1 cells (23). It is of interest that, in addition to SP-A and lysozyme, the lysosomal enzymes acid phosphatase (1,21) and cathepsin H (22), have been shown to have a similar peripheral localization pattern in lamellar bodies. Eckenhoff and Somlyo (9) found sulfur, an element common to proteins, to be concentrated in the periphery of lamellar bodies in elemental analysis studies of cryofixed adult rat lung sections, but a similar pattern was not found in fetal rat lung Type I1 cells (8), possibly due to an inability of these cells to recycle surfactant components. The above findings are consistent with the concept that lamellar bodies are functionally multicompartmented organelles involved in the storage, secretion, recycling, and degradation of many proteins whose regulation and functions within the lung surfactant system have not been as yet defined.
Distribution of SP-A and Lysozyme in Extracellular Surfactant
A novel approach of the present study is the morphometric evaluation of serially sectioned alveolar pouches, which facilitated the comparative evaluation of the immunolabeling pattern among extracellular surfactant forms. In these pouches, both SP-A and lysozyme show prominent localization within tubular myelin when compared with other extracellular surfactant forms.
In our gold labeling studies of tubular myelin, both SP-A and lysozyme were localized at the membranes with a particle density higher than 95 %, but not at any specific region of the lattice structure. The tubular myelin lattice in our preparations measured 60 nm from one corner of the lattice to its nearest neighboring corner. Using a distance of 20 nm from any corner as a defining parameter in particle counting, each 60 nm side of a lattice would have 213 or 40 nm assigned to corners. Our gold particle counts reflect approximately 213 (64%) of the particles labeling SP-A occurring within 20 nm of a corner, and thus revealing no preferential association of particles with corners of the lattice. Voorhout et al. (38) reported that in isolated surfactant fractions 79% of the gold label for SP-A was localized within 20 nm from the corners of the tubular myelin lattice. This level of localization is only 12 % higher than the predicted level (67%) of random distribution, which contrasts with the striking gold label density (98%) for the lattice membranes reported herein. Voorhout et al. (38) also found no SP-A labeling of other surfactant forms present in tubular myelin-enriched fractions isolated from lavage fluid. This is at variance with our results that were obtained by in situ fixation of secreted surfactant membranes. Procedures for isolating tubular myelin from lung lavage may have promoted artifactual loss or translocation of SP-A before fixation. In addition, the use of osmium tetroxide in the cryosubstitution medium by Voorhout and co-workers may have reduced the number of antigenic sites present in their preparations owing to protein denaturing.
On the basis of our morphometric data, there is a significant difference between the distribution of SP-A and lysozyme in densely coiled lamellar body-like forms and in multilamellar structures. The peripheral membranes of lamellar body-like forms reveal an in- : a,b,d x 40,000; c x 100,000, Bars = 0.25 bm. .. .. creased label density for SP-A when compared with the peripheral compartment of lamellar bodies, suggesting that, after secretion peripheral membranes of unwinding lamellar bodies become enriched with extracellular SP-A. A further increase in labeling for SP-A was found in multilamellar structures, which apparently represent intermediate forms before the formation of tubular myelin. In contrast, label for lysozyme over the central membranes of lamellar body-like forms increases fivefold over label in the center of lamellar bodies, with a two-to threefold decrease in label over peripheral membranes, suggesting a uniform spreading of lysozyme throughout these structures after secretion. The above contrasting changes may reflect the existence of different modulatory actions by these proteins during secretion and unwinding of surfactant membranes.
Original magnifications
Unilamellar vesicles also show increased labeling for SP-A when compared with all other surfactant forms except tubular myelin. Wright et al. (42) reported that SP-A enhances the in vitro uptake of DPPC vesicles by Type I1 cells. There is evidence that in vitro conversion of tubular myelin to unilamellar vesicles requires serine proteinase activity (13) and may represent a mechanism of surfactant degradation. Endocytosis of unilamellar vesicles by Type I1 cells could provide a mechanism for recycling of surfactant, resulting in the accumulation of SP-A and lysozyme in the peripheral compartment of lamellar bodies.
Biochemical studies have indicated that lysozyme is an oxidantsensitive lamellar body protein which is rapidly depleted during acute ozone-mediated alveolar injury and subsequent repair (30). This lysozyme deficiency is associated with time-dependent structural defects in the organization of stored and secreted surfactant membranes (3). In addition, other investigators have recently reported that in vitro exposure of SP-A to ozone results in stmctural and functional changes of this protein, which may contribute to ozone-induced defects in the lung surfactant system (27). On the basis of these observations and the results of the present study, we are presently exploring the hypothesis that lysozyme, in concert with SP-A and other surfactant-associated proteins, participates in the regulation of secretion, organization, and recycling of surfactant membranes. 
